URYCVE traded at 2.42170 this Monday February 2nd, increasing 0.02418 or 1.01 percent since the previous trading session. Looking back, over the last four weeks, URYCVE gained 0.19 percent. Over the last 12 months, its price fell by 1.63 percent. Looking ahead, we forecast URYCVE to be priced at 2.41463 by the end of this quarter and at 2.41381 in one year, according to Trading Economics global macro models projections and analysts expectations.